CXCL12 and cancer: Since stromal-vascular BM niches secrete abundant CXCL12, whereas CXCR4 is primarily expressed on HSCs and malignant cells, the CXCL12/CXCR4 axis becomes a key pathway for both normal hematopoiesis and cancer cell homing to the BM [62,63,64,65].